Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CRSP

CRISPR Therapeutics AG

Mar 10 • 04:00PM ET

43.34

Dollar change -2.19
Percentage change -4.81	%

Healthcare • Biotechnology • Switzerland • NASD

Peers: EDIT NTLA BEAM SGMO VRTX GILD BLUE ALLO CLLS ADPT

| Held by: ARKK ARKG XBI VXF IBB SCHA VHT XT SCHM LABU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.36	Insider Own	4.32%	Shs Outstand	85.74M	Perf Week	2.48%
Market Cap	3.72B	Forward P/E	-	EPS next Y	-4.05	Insider Trans	-2.43%	Shs Float	82.07M	Perf Month	6.72%
Income	-366.25M	PEG	-	EPS next Q	-1.23	Inst Own	69.38%	Short Float	24.87%	Perf Quarter	-15.25%
Sales	37.31M	P/S	99.64	EPS this Y	-10.94%	Inst Trans	2.81%	Short Ratio	9.31	Perf Half Y	-4.22%
Book/sh	22.53	P/B	1.92	EPS next Y	15.91%	ROA	-16.38%	Short Interest	20.41M	Perf Year	-46.38%
Cash/sh	22.20	P/C	1.95	EPS next 5Y	15.85%	ROE	-19.20%	52W Range	36.52 - 81.73	Perf YTD	10.11%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-17.13%	52W High	-46.97%	Beta	1.74
Dividend TTM	-	Quick Ratio	22.07	Sales past 5Y	31550.17%	Gross Margin	-247.24%	52W Low	18.67%	ATR (14)	2.95
Dividend Ex-Date	-	Current Ratio	22.07	EPS Y/Y TTM	-123.71%	Oper. Margin	-1250.38%	RSI (14)	47.66	Volatility	6.98% 6.83%
Employees	393	Debt/Eq	0.12	Sales Y/Y TTM	-89.95%	Profit Margin	-981.54%	Recom	1.97	Target Price	80.33
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	-139.74%	Payout	-	Rel Volume	1.35	Prev Close	45.53
Sales Surprise	343.09%	EPS Surprise	63.35%	Sales Q/Q	-82.26%	Earnings	Feb 11 AMC	Avg Volume	2.19M	Price	43.34
SMA20	-4.10%	SMA50	1.56%	SMA200	-11.27%	Trades		Volume	2,929,735	Change	-4.81%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-14-25	Upgrade	Evercore ISI	In-line → Outperform	$60 → $99
Feb-12-25	Upgrade	TD Cowen	Sell → Hold	$35
Feb-03-25	Initiated	H.C. Wainwright	Buy	$65
Aug-06-24	Reiterated	Needham	Buy	$88 → $84
Aug-02-24	Initiated	Rodman & Renshaw	Buy	$90
Jun-28-24	Resumed	Guggenheim	Neutral
Feb-15-24	Initiated	Wolfe Research	Peer Perform
Dec-11-23	Downgrade	TD Cowen	Market Perform → Underperform	$30
Oct-17-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-27-23	Initiated	Mizuho	Buy	$82
Aug-17-23	Upgrade	Citigroup	Neutral → Buy
May-30-23	Initiated	William Blair	Outperform	$75
Apr-13-23	Initiated	Cantor Fitzgerald	Overweight	$72
Mar-21-23	Initiated	Bernstein	Mkt Perform	$44
Mar-17-23	Initiated	Bryan Garnier	Buy	$70
Mar-07-23	Initiated	Robert W. Baird	Neutral	$46
Oct-11-22	Initiated	Morgan Stanley	Underweight	$37
Aug-09-22	Downgrade	Barclays	Overweight → Equal Weight	$99 → $88
Jun-23-22	Downgrade	Evercore ISI	Outperform → In-line	$66 → $60
Jun-17-22	Initiated	BMO Capital Markets	Outperform	$98

Show Previous Ratings

Mar-03-25 09:00AM	CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Feb-28-25 03:15AM	3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%. (Motley Fool)
Feb-26-25 08:00AM	CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-24-25 10:00AM	2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street (Motley Fool)
Feb-23-25 01:34PM	CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts (Insider Monkey)
12:01PM	Loading…
Feb-20-25 12:01PM	CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now (Insider Monkey)
09:00AM	CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Feb-16-25 05:34AM	Street Calls of the Week (Investing.com)
Feb-15-25 02:00AM	Why CRISPR Therapeutics (CRSP) Soared on Friday? (Insider Monkey)
Feb-14-25 12:20PM	CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99 (GuruFocus.com) +14.33%
10:38AM	CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment (GuruFocus.com)
Feb-12-25 06:37PM	Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday (Motley Fool) +9.29%
11:26AM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
10:25AM	Crispr Therapeutics price target raised to $86 from $85 at BofA (TipRanks)
Feb-11-25 05:10PM	CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Loading…
04:01PM	CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-10-25 05:50PM	CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know (Zacks)
06:15AM	Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move (Motley Fool)
Feb-06-25 08:13PM	CRISPR Therapeutics AG (CRSP): Among Cathie Woods Top Stock Picks for 2025 (Insider Monkey)
Feb-04-25 06:00PM	Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today (Zacks)
Jan-30-25 01:50PM	Jim Cramer Says CRISPR (CRSP) Keeps Losing Money Like Moderna Heres Why (Insider Monkey)
Jan-29-25 05:50PM	CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors (Zacks)
08:00AM	CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference (GlobeNewswire)
Jan-24-25 06:00PM	CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Jan-23-25 08:30AM	CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last? (Zacks)
04:15AM	My Top 5 Stocks to Buy in Early 2025 (Motley Fool)
Jan-17-25 11:16AM	CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential (Insider Monkey)
Jan-16-25 08:00AM	2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows (Motley Fool)
03:15AM	My 10 Top Stocks to Buy to Start the New Year Off Right (Motley Fool)
Jan-14-25 06:00PM	CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
04:34AM	Loading…
04:34AM	Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts (Motley Fool)
Jan-13-25 07:00AM	CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones (GlobeNewswire)
Jan-09-25 04:20AM	3 Mid-Cap Stocks That Could Take Off in 2025 (Motley Fool)
Jan-08-25 08:30AM	CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-07-25 06:00PM	CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
08:00AM	CRISPR Therapeutics Proposes New Appointment to the Board of Directors (GlobeNewswire)
07:19AM	Vertex, startup Orna to partner on gene editing research (BioPharma Dive)
Dec-31-24 05:50PM	CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know (Zacks) +5.26%
Dec-30-24 03:47PM	Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In? (Insider Monkey)
Dec-29-24 06:36AM	CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now? (Insider Monkey)
Dec-26-24 06:00PM	CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors (Zacks)
Dec-22-24 12:25PM	This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? (Motley Fool)
Dec-20-24 09:30AM	1 Big New Green Flag for CRISPR Therapeutics' Stock (Motley Fool)
Dec-17-24 05:29AM	2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? (Motley Fool)
Dec-14-24 09:45AM	3 Things You Need to Know if You Buy CRISPR Therapeutics Today (Motley Fool)
Dec-12-24 12:37PM	Editas to lay off staff after search for sickle cell partner comes up empty (BioPharma Dive)
Dec-11-24 11:45AM	Is CRISPR Therapeutics AG (CRSP) the Worst ARK Stock to Buy According to Short Sellers? (Insider Monkey)
Dec-09-24 12:00PM	CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Dec-07-24 08:45AM	2 Biotech Stocks to Buy Hand Over Fist in December (Motley Fool)
Dec-06-24 12:00PM	CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) +5.70%
Dec-05-24 11:30AM	Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report? (Zacks)
05:27AM	3 of the Best Growth Stocks You Can Buy for Less than $100 (Motley Fool)
Dec-02-24 05:44PM	Wall Street Analysts Think CRISPR Therapeutics (CRSP) Could Surge 58.3%: Read This Before Placing a Bet (Zacks) +7.78% -7.09%
Nov-30-24 04:35AM	Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65% (Motley Fool)
Nov-24-24 05:47AM	Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip? (Motley Fool)
Nov-23-24 06:30AM	3 Monster Stocks in the Making (Motley Fool)
Nov-21-24 05:15PM	Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024? (Insider Monkey)
Nov-19-24 07:03PM	CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
Nov-18-24 06:53AM	CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest (BioPharma Dive)
Nov-17-24 05:11PM	CRISPR Therapeutics AG (CRSP): Among ARK Invest's Top Stock Picks for 2024 (Insider Monkey)
Nov-16-24 06:00AM	2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More (Motley Fool)
Nov-15-24 05:45AM	Where Will CRISPR Therapeutics Be in 3 Years? (Motley Fool)
Nov-14-24 08:30AM	CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference (GlobeNewswire) -5.90%
Nov-13-24 06:30AM	3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029 (Motley Fool)
Nov-08-24 05:20PM	Elon Musk will be 'vitally important' in Trump admin: Cathie Wood (Yahoo Finance Video) +6.28%
01:22PM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Nov-07-24 08:00AM	CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference (GlobeNewswire)
Nov-06-24 12:42PM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
09:55AM	Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High? (Zacks)
Nov-05-24 10:10AM	CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
09:01AM	CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results (GlobeNewswire)
05:00AM	3 Companies Building Tomorrow's Game-Changing Technologies (Motley Fool)
Nov-04-24 09:35AM	CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average (Zacks)
09:30AM	CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Nov-02-24 10:00AM	Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers (Motley Fool)
Oct-31-24 04:02AM	Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock? (Insider Monkey)
Oct-26-24 06:32AM	The Ultimate Biotech Stock to Buy With $50 Right Now (Motley Fool)
Oct-25-24 05:50PM	CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Oct-22-24 11:50AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Oct-21-24 06:00PM	CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
09:55AM	Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High? (Zacks)
Oct-19-24 07:30AM	3 Bargain Stocks to Buy in a Market That's Priced for Perfection (Motley Fool)
Oct-16-24 03:47PM	Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
09:45AM	Why I Keep Buying These 14 Incredible Growth Stocks (Motley Fool)
Oct-15-24 06:00PM	CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors (Zacks)
Oct-13-24 06:30AM	Is CRISPR Therapeutics Stock a Buy? (Motley Fool)
Oct-12-24 08:30AM	2 Biotech Stocks That Are Screaming Buys This Month (Motley Fool)
Oct-08-24 06:00PM	CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why (Zacks)
Oct-05-24 04:25AM	This Healthcare Growth Stock Could Be a Steal of a Deal Right Now (Motley Fool)
Oct-04-24 07:13PM	Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m (Pharmaceutical Technology)
Oct-02-24 06:00PM	Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today (Zacks)
05:00AM	Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now (Quartz)
04:55AM	These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer (Motley Fool)
Sep-25-24 06:00PM	CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know (Zacks)
Sep-21-24 07:36AM	3 Dirt Cheap Stocks to Buy Right Now (Motley Fool)
Sep-19-24 05:50PM	CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
04:33AM	Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy? (Motley Fool)
Sep-18-24 06:00PM	CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know (Zacks)
Sep-12-24 08:45AM	1 Biotech Stock Down 62% to Buy and Hold (Motley Fool)
04:15AM	3 No-Brainer Biotech Stocks to Buy With $200 Right Now (Motley Fool)

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Greene John	Director	Feb 26 '25	Buy	44.85	7,000	313,948	7,000	Feb 28 05:35 PM
Kulkarni Samarth	Chief Executive Officer	Feb 19 '25	Sale	55.20	18,360	1,013,564	171,613	Feb 21 05:35 PM
Kulkarni Samarth	Chief Executive Officer	Feb 18 '25	Sale	55.05	11,640	640,782	196,901	Feb 19 05:35 PM
Kulkarni Samarth	Chief Executive Officer	Feb 19 '25	Sale	52.80	6,928	365,798	189,973	Feb 19 05:35 PM
Bruno Julianne	Chief Operating Officer	Feb 19 '25	Sale	52.80	333	17,582	7,062	Feb 19 05:35 PM
KASINGER JAMES R.	General Counsel and Secretary	Feb 18 '25	Sale	53.85	9,595	516,691	73,002	Feb 19 05:35 PM
KASINGER JAMES R.	General Counsel and Secretary	Feb 19 '25	Sale	52.80	1,947	102,802	74,880	Feb 19 05:35 PM
Samarth Kulkarni	Officer	Feb 18 '25	Proposed Sale	52.22	45,000	2,349,900		Feb 18 05:35 PM
Kulkarni Samarth	Chief Executive Officer	Dec 24 '24	Option Exercise	16.21	13,751	222,904	195,291	Dec 27 05:35 PM
Kulkarni Samarth	Chief Executive Officer	Dec 02 '24	Sale	55.10	15,000	826,564	181,540	Dec 04 05:35 PM
Kulkarni Samarth	Chief Executive Officer	Nov 11 '24	Sale	55.62	30,000	1,668,678	196,540	Nov 13 05:35 PM
KASINGER JAMES R.	General Counsel and Secretary	Oct 14 '24	Sale	46.28	1,089	50,399	62,597	Oct 15 06:00 PM
Kulkarni Samarth	Chief Executive Officer	Oct 14 '24	Sale	46.28	4,293	198,680	226,540	Oct 15 06:00 PM
Bruno Julianne	Chief Operating Officer	Jun 21 '24	Sale	56.09	3,366	188,799	6,745	Jun 24 05:35 PM
Kulkarni Samarth	Chief Executive Officer	Apr 15 '24	Option Exercise	19.12	19,582	374,408	227,704	Apr 17 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Apr 15 '24	Sale	59.91	19,582	1,173,232	208,122	Apr 17 05:45 PM
Prasad Raju	Chief Financial Officer	Mar 15 '24	Sale	72.69	3,524	256,160	6,476	Mar 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 15 '24	Option Exercise	19.12	20,000	382,400	228,122	Mar 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 15 '24	Sale	72.48	20,000	1,449,628	208,122	Mar 18 05:45 PM
KASINGER JAMES R.	General Counsel and Secretary	Mar 12 '24	Sale	74.44	1,146	85,308	61,174	Mar 12 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 12 '24	Sale	74.44	4,583	341,159	208,122	Mar 12 05:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRSP

CRISPR Therapeutics AG

Upgrade your FINVIZ experience